Standout Papers

Bevacizumab in Combination With Oxaliplatin-Based Chemotherapy As First-Line Therapy in Metastat... 2008 2026 2014 2020 2.2k
  1. Bevacizumab in Combination With Oxaliplatin-Based Chemotherapy As First-Line Therapy in Metastatic Colorectal Cancer: A Randomized Phase III Study (2008)
    Leonard B. Saltz, Stephen Clarke et al. Journal of Clinical Oncology

Immediate Impact

14 from Science/Nature 80 standout
Sub-graph 1 of 15

Citing Papers

Final results of DESTINY-CRC01 investigating trastuzumab deruxtecan in patients with HER2-expressing metastatic colorectal cancer
2023 Standout
Lysine catabolism reprograms tumour immunity through histone crotonylation
2023 StandoutNature
4 intermediate papers

Works of Ralph Wong being referenced

Location of colon cancer (right-sided versus left-sided) as a prognostic factor and a predictor of benefit from cetuximab in NCIC CO.17
2015
Bevacizumab in Combination With Oxaliplatin-Based Chemotherapy As First-Line Therapy in Metastatic Colorectal Cancer: A Randomized Phase III Study
2008 Standout

Author Peers

Author Last Decade Papers Cites
Ralph Wong 2789 1121 131 938 36 3.4k
G. Ganem 3223 1124 119 976 67 4.4k
Guy van Hazel 3659 1769 126 1072 66 5.1k
Isabelle Tabah-Fisch 3614 1011 91 490 23 4.5k
Ilhan Celik 2782 1615 34 569 30 3.8k
O. Kisker 2009 858 35 491 43 3.3k
P Rougier 3024 1155 49 1197 67 3.8k
D. Papamichael 2989 935 55 904 26 3.6k
Frans Erdkamp 2661 1270 76 463 81 3.6k
Abdel Hmissi 2668 883 40 890 34 4.1k
Jean–Luc Van Laethem 3038 1423 67 554 47 3.7k

All Works

Loading papers...

Rankless by CCL
2026